ATARA BIOTHERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 173.28 thousand shares for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2018-05-08
- ATARA BIOTHERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-03-31 was 173.28K shares, a 52.95% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-12-31 was 158.78K shares, a 12.22% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-09-30 was 102.17K shares, a 1750.92% increase year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-06-30 was 38.84K shares, a 72.62% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 413.07K shares, a 14.75% increase from fiscal 2016.
- ATARA BIOTHERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2016 was 359.99K shares, a 394.76% increase from fiscal 2015.
- ATARA BIOTHERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 72.76K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2018-03-31 | 173.28K shares 10-Q · filed 2018-05-08 | 332.05K shares derived: sum of 2 quarters · filed 2018-05-08 | 434.22K shares derived: sum of 3 quarters · filed 2018-05-08 | 473.06K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 158.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 260.95K shares derived: sum of 2 quarters · filed 2018-02-27 | 299.79K shares derived: sum of 3 quarters · filed 2018-02-27 | 413.07K shares 10-K · filed 2018-02-27 |
| 2017-09-30 | 102.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 141.01K shares derived: sum of 2 quarters · filed 2017-11-09 | 254.30K shares 10-Q · filed 2017-11-09 | 435.18K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 38.84K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 152.13K shares 10-Q · filed 2017-08-07 | 333.01K shares derived: sum of 3 quarters · filed 2017-08-07 | 338.53K shares derived: sum of 4 quarters · filed 2017-08-07 |
| 2017-03-31 | 113.29K shares 10-Q · filed 2017-05-04 | 294.17K shares derived: sum of 2 quarters · filed 2017-05-04 | 299.69K shares derived: sum of 3 quarters · filed 2017-05-04 | 441.57K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 180.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | 186.40K shares derived: sum of 2 quarters · filed 2017-03-09 | 328.28K shares derived: sum of 3 quarters · filed 2017-03-09 | 359.99K shares 10-K · filed 2017-03-09 |
| 2016-09-30 | 5.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | 147.40K shares derived: sum of 2 quarters · filed 2016-11-04 | 179.11K shares 10-Q · filed 2016-11-04 | 179.11K shares derived: sum of 4 quarters · filed 2016-11-04 |
| 2016-06-30 | 141.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 173.59K shares 10-Q · filed 2016-08-08 | 173.59K shares derived: sum of 3 quarters · filed 2016-08-08 | 242.59K shares derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | 31.70K shares 10-Q · filed 2016-05-06 | 31.70K shares derived: sum of 2 quarters · filed 2016-05-06 | 100.70K shares derived: sum of 3 quarters · filed 2016-05-06 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-04 | 69.00K shares derived: sum of 2 quarters · filed 2016-03-04 | 72.76K shares 10-K · filed 2016-03-04 | |
| 2015-09-30 | 69.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 72.76K shares 10-Q · filed 2015-11-06 | ||
| 2015-06-30 | 3.76K shares 10-Q · filed 2015-08-07 | |||
| 2014-09-30 | 0.00 shares 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |